This multicentric retrospective study analysed EMRs of 5205 GERD patients in India to assess partial
Pantoprazole, a widely prescribed proton pump inhibitor, is essential for managing acid-related disorders. Approved for
Eosinophilic Esophagitis (EoE) is a chronic immune-mediated disease presenting with esophageal dysfunction and eosinophilic infiltration.
A randomized, open-label study compared pantoprazole alone with pantoprazole plus amitriptyline in functional dyspepsia patients.